Free Trial

Ocular Therapeutix (OCUL) SEC Filings & 10K Form

Ocular Therapeutix logo
$12.21 -0.09 (-0.73%)
Closing price 04:00 PM Eastern
Extended Trading
$12.22 +0.01 (+0.08%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
08/05/2025
6:06 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
6:11 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2025
8:07 AM
FMR LLC (Filed by)
Ocular Therapeutix (Subject)
Form SCHEDULE 13G
06/23/2025
8:09 PM
Ocular Therapeutix (Issuer)
Saroj Namrata (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2025
8:12 PM
Meyers Steve Lawrence (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2025
3:21 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:23 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
3:24 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:40 PM
Ocular Therapeutix (Subject)
Waheed Nadia (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
4:39 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:40 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:42 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
4:37 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:07 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
3:08 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
7:45 AM
Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
Form SCHEDULE 13G/A
05/12/2025
7:50 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:47 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
6:06 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
4:00 PM
Ocular Therapeutix (Filer)
Form DEF 14A
04/29/2025
4:01 PM
Ocular Therapeutix (Filer)
Form DEFA14A
03/03/2025
6:19 AM
Ocular Therapeutix (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:07 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
5:27 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:22 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:24 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
5:25 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
3:33 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
6:32 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:46 AM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:36 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:37 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:38 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:35 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
6:16 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
6:52 AM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:49 AM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:51 AM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:47 AM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump set to Boost Social Security Checks by 400%? (Ad)

If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...

Click here to see the details because the stakes couldn't be any higher.
11/25/2024
5:42 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:19 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:23 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:44 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:10 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:49 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:37 AM
Avoro Capital Advisors LLC (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
11/14/2024
6:30 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
6:10 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:15 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
3:49 PM
Ocular Therapeutix (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
10/16/2024
3:25 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:31 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
4:32 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:17 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:18 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:20 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:21 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:01 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
4:17 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:19 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:18 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:36 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
4:32 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCUL) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners